The Mind-Body Interface: Maximizing Peak Performance.

Psychiatr Clin North Am

Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, New York, NY 10029, USA. Electronic address:

Published: September 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2021.06.001DOI Listing

Publication Analysis

Top Keywords

mind-body interface
4
interface maximizing
4
maximizing peak
4
peak performance
4
mind-body
1
maximizing
1
peak
1
performance
1

Similar Publications

Essential hypertension (EH) with secondary insomnia is associated with increased risks of neuroinflammation, neuronal damage, and Alzheimer's disease (AD). However, its relationship with specific cerebrospinal fluid (CSF) biomarkers of neuronal damage and neuroinflammation remains unclear. This case-control study compared CSF biomarker levels across three groups: healthy controls (HC, n = 64), hypertension-controlled (HTN-C, n = 54), and hypertension-uncontrolled (HTN-U, n = 107) groups, all EH participants experiencing secondary insomnia.

View Article and Find Full Text PDF

Wearable, self-administered transcranial photobiomodulation for major depressive disorder and sleep: A randomized, double blind, sham-controlled trial.

J Affect Disord

December 2024

Mind-Body Interface Research Centre (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; An-Nan Hospital, China Medical University, Tainan, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan. Electronic address:

Background: Device-based treatments exist in psychiatry for decades, but are usually operated by clinicians and require multiple office visits. Near-infrared transcranial photobiomodulation (tPBM) is a safe neurostimulation modality with potential antidepressant and hypnotic effects. We investigated the feasibility and efficacy of adjunctive tPBM treatment, self-administered by a wearable headband.

View Article and Find Full Text PDF

Research on nutraceutical and dietary interventions in psychiatry has grown substantially, but progress is hindered by methodological inconsistencies and limited reporting standards. To address this, the International Society for Nutritional Psychiatry Research presents the first guidelines on clinical trial design, conduct, and reporting for future clinical trials in this area. Recommendations were developed using a Delphi process including eighteen researchers with considerable clinical trial expertise and experience in either methodology, nutraceutical, or dietary interventions in psychiatry.

View Article and Find Full Text PDF

Pharmacologic prophylaxis of postoperative delirium in elderly patients: A network meta-analysis of randomized controlled trials.

J Psychiatr Res

November 2024

Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan; An-Nan Hospital, China Medical University, Tainan, Taiwan. Electronic address:

Article Synopsis
  • The study addresses the high rates of postoperative delirium (POD) in elderly patients and seeks to evaluate the effectiveness of various pharmacological interventions to prevent it.
  • A network meta-analysis was performed on 44 randomized controlled trials (RCTs) with 11,178 patients, focusing on the incidence of POD and tolerability of treatments.
  • Results showed that atypical antipsychotics were the most effective in reducing delirium, while no significant differences were found in dropout rates or all-cause mortality among the treatment groups compared to placebo.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!